Recital 10, Regulation (EU) 2018/1500

In forcesince 9 Oct 2018cited 1×

However, despite the arguments put forward by the applicant, the concerns related to the substance could not be eliminated.

  • Judgment of the General Court (Seventh Chamber) of 9 February 2022. Taminco BVBA and Arysta LifeScience Great Britain Ltd v European CommissDecision

    Recitals 8 to 11 of the contested implementing regulation set out the reasons for the non-renewal as follows: On 27 January 2017, [EFSA] communicated to the Commission its conclusion on whether thiram can be expected to meet the approval …

    9 Feb 2022 · 62018TJ0740